Overview
Portfolio
More
Maxpro Ventures
Taipei, Taiwan
Invests in biomedical technology companies developing innovative drugs, devices, diagnostics, and services to meet unmet medical needs globally.
Portfolio
24+
Employees
5+
Founded
2013
AUM
≈ $1.0B
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
ChinaTaiwanUnited States
Sources
Maxpro Ventures
Invests in biomedical technology companies developing innovative drugs, devices, diagnostics, and services to meet unmet medical needs globally.
Portfolio
24+
Employees
5+
Founded
2013
AUM
≈ $1.0B
Stages
No stages listed
Industries
No industries listedGeographic scope
ChinaTaiwanUnited States
Sources
Showing 21 of 21 matched portfolio companies
Acepodia develops first-in-class cell therapies utilizing Antibody-Cell Conjugation (ACC) technology to enhance the potency and specificity of immune cells against cancer. The company addresses the limitations of traditional cancer treatments by providing targeted therapies that do not require genetic engineering, improving safety and efficacy across various tumor types.
Funding: $100.0M
Rough estimate of the amount of funding raised
Funding: $100.0M
Rough estimate of the amount of funding raised
ACT Genomics provides genomic profiling services that deliver actionable insights on biomarkers and genomic alterations to tailor cancer treatment plans for patients. By utilizing precision testing, the company enhances treatment selection and clinical trial matching, improving patient outcomes in oncology.
This company specializes in programming robotics solutions tailored for hybrid manufacturing environments. They provide the necessary software and integration services to automate complex production workflows. The core value is enabling manufacturers to efficiently combine different production methods using advanced robotic control systems.
Funding: $1.1M
Rough estimate of the amount of funding raised
Funding: $1.1M
Rough estimate of the amount of funding raised
The startup develops protein degradation drugs using an AI-enabled platform to identify and target disease-related proteins in cancer, neurodegenerative, and aging-related diseases. This approach provides researchers and pharmaceutical companies with a new class of therapeutics that can overcome drug resistance in life-threatening conditions.
Funding: $10.0M
Rough estimate of the amount of funding raised
Funding: $10.0M
Rough estimate of the amount of funding raised
Anya is a pregnancy and parenting app that utilizes AI and 3D animation to provide evidence-based information and support for families during the critical 1,001 days of parenting. The platform addresses the need for accessible, reliable resources in women's health, enhancing the parenting experience for over 7 million families in the UK.
Apollomics is a biopharmaceutical company focused on discovering and developing mono- and combination therapies that leverage the immune system to target specific molecular pathways in cancer treatment. The company aims to provide effective options for patients who have exhausted existing treatment alternatives, improving their clinical outcomes.
Funding: $23.6M
Rough estimate of the amount of funding raised
Funding: $23.6M
Rough estimate of the amount of funding raised
BC Partners is an international alternative investment firm specializing in private equity, credit, and real estate strategies. The firm provides institutional investors with tailored investment solutions to enhance portfolio diversification and optimize returns in complex market environments.
CHAI is an AI platform that utilizes techniques such as Reinforcement Learning from Human Feedback (RLHF) and long-context modeling to create engaging conversational agents. The platform addresses the challenge of generating AI interactions that are both factually accurate and socially entertaining, empowering users to create and share their own content.
Funding: $10.0M
Rough estimate of the amount of funding raised
Funding: $10.0M
Rough estimate of the amount of funding raised
Elixiron Immunotherapeutics develops therapeutics for cancer and immunological diseases using phage display and single human B cell cloning to create biologics and small molecule inhibitors. Their focus includes targeting specific pathways such as IFN-γ and CSF1R to address conditions like vitiligo, Alzheimer's disease, and various cancers.
Funding: $13.8M
Rough estimate of the amount of funding raised
Funding: $13.8M
Rough estimate of the amount of funding raised
Gen+ is a digital platform that provides leadership and meta-skills education for learners aged 9-14 and their teachers, utilizing a blended learning approach that combines online and in-person instruction. The program addresses the lack of standardized skills development in schools by equipping students with essential, transferable skills necessary for success in learning, work, and life.
Funding: $100.7K
Rough estimate of the amount of funding raised
Funding: $100.7K
Rough estimate of the amount of funding raised
HARM provides an AI-powered platform for individuals experiencing harm to quickly access immediate, trusted support. The system intelligently identifies the nature of the reported harm and routes users directly to appropriate, city-approved advocacy, legal, or housing resources. This streamlined process eliminates confusion while generating de-identified data insights to help municipal leaders optimize community support services.
Heal is a nonprofit ecommerce platform that utilizes experience-based peer support to help individuals with mental illness reconnect with their passions through creative expression. By empowering emerging artists to showcase their work, Heal reinvests 100% of its profits into community-building initiatives that foster meaningful connections.
The startup offers an online hiring platform that enables businesses to recruit and manage remote interns and staff through integrated tools for task management, attendance tracking, and messaging. This platform facilitates efficient communication and collaboration for remote teams, providing young graduates with opportunities to work for international companies.
Funding: $440.0K
Rough estimate of the amount of funding raised
Funding: $440.0K
Rough estimate of the amount of funding raised
J2H Biotech develops small-molecule drugs targeting intractable rare diseases through precision chemistry and targeted protein degradation techniques. The company addresses the unmet medical needs of patients suffering from conditions that currently lack effective treatment options.
Neuron provides automated EEG data analysis that translates complex brainwave activity into five quantifiable cognitive states, including mental fatigue and cognitive load, in real time. The company also offers custom neuroscience studies that collect and analyze brainwave data to deliver actionable business insights for wellness, training, and marketing teams.
Nx provides a build system optimized for monorepos, featuring plugins for popular frameworks and advanced CI capabilities such as remote caching and task distribution. It addresses the inefficiencies of traditional CI systems by significantly reducing build times and costs, enabling developers to ship products faster and more reliably.
Funding: $16.0M
Rough estimate of the amount of funding raised
Funding: $16.0M
Rough estimate of the amount of funding raised
Plus is an AI-powered presentation tool that integrates directly with PowerPoint and Google Slides, allowing users to create, edit, and automate slide decks efficiently. It converts various document formats into professional presentations and offers features like individual slide creation and reformatting of existing decks, significantly reducing the time spent on presentation design.
Funding: $2.5M
Rough estimate of the amount of funding raised
Funding: $2.5M
Rough estimate of the amount of funding raised
Ro operates a telehealth platform that provides online clinics for weight loss, sexual health, hair restoration, and fertility management using clinically proven treatments and prescription medications. The service eliminates the need for insurance and offers free, discreet shipping, making healthcare accessible and convenient for over 2 million members.
See offers a live interactive video platform that enables real-time video sharing across iOS, Android, and web applications, facilitating shared viewing experiences among users regardless of their location. This technology enhances social connectivity by allowing friends to engage in simultaneous video consumption, bridging the gap created by physical distance.
The startup offers a platform that enables businesses to generate revenue without any upfront investment by providing a full customer experience service and 360-degree protection for their financial solutions. It addresses the challenge of financial accessibility and inflation risk, allowing users to earn guaranteed cash while minimizing their financial exposure.
Tern provides a low-code platform for brands to quickly launch customizable banking products, including virtual and physical prepaid cards, while ensuring compliance through robust back-office tools. This solution addresses the need for efficient onboarding and fund management in a secure environment, enabling businesses to streamline financial operations and enhance cash flow.
Showing 3 of 3 unmatched portfolio companies
Tripartite Therapeutics
No website provided
We don't have a full profile for this company yet.
StellarCell BioMedicine
No website provided
We don't have a full profile for this company yet.
Original Biomedical
No website provided
We don't have a full profile for this company yet.